[HTML][HTML] Deep vein thrombosis: pathogenesis, diagnosis, and medical management

J Stone, P Hangge, H Albadawi, A Wallace… - Cardiovascular …, 2017 - ncbi.nlm.nih.gov
Deep vein thrombosis (DVT) is a major preventable cause of morbidity and mortality
worldwide. Venous thromboembolism (VTE), which includes DVT and pulmonary embolism …

Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery® and the American Venous Forum

TF O'Donnell, MA Passman, WA Marston… - Journal of vascular …, 2014 - jvascsurg.org
Guideline 3.11: Venous Imaging We suggest selective computed tomography venography,
magnetic resonance venography, contrast venography, and/or intravascular ultrasound in …

Editor's Choice–European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis

SK Kakkos, M Gohel, N Baekgaard… - European Journal of …, 2021 - ejves.com
2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

[HTML][HTML] Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis

S Vedantham, SZ Goldhaber, JA Julian… - … England Journal of …, 2017 - Mass Medical Soc
Background The post-thrombotic syndrome frequently develops in patients with proximal
deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical …

Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report

C Kearon, EA Akl, J Ornelas, A Blaivas, D Jimenez… - Chest, 2016 - Elsevier
Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …

The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs

SD Grosse, RE Nelson, KA Nyarko, LC Richardson… - Thrombosis research, 2016 - Elsevier
Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary
embolism, is an important cause of preventable mortality and morbidity. In this study, we …

Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …

C Kearon, EA Akl, AJ Comerota, P Prandoni… - Chest, 2012 - Elsevier
Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …

The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association

SR Kahn, AJ Comerota, M Cushman, NS Evans… - Circulation, 2014 - Am Heart Assoc
Methods Members of the writing panel were invited by the American Heart Association
Scientific Council leadership because of their multidisciplinary expertise in PTS. Writing …

Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre …

P Notten, AJ ten Cate-Hoek… - The Lancet …, 2020 - thelancet.com
Background Early thrombus removal might prevent post-thrombotic syndrome by preserving
venous function and restoring flow. Previous trials comparing additional catheter-directed …

Endovascular thrombus removal for acute iliofemoral deep vein thrombosis: analysis from a stratified multicenter randomized trial

AJ Comerota, C Kearon, CS Gu, JA Julian… - Circulation, 2019 - Am Heart Assoc
Background: The ATTRACT trial (Acute Venous Thrombosis: Thrombus Removal with
Adjunctive Catheter-Directed Thrombolysis) previously reported that pharmacomechanical …